Most colorectal cancer patients develop metastasis to the liver during the course of the disease. The success of metastatic hepatic cancer treatment is strongly dependent on early diagnosis and understanding of the mo...Most colorectal cancer patients develop metastasis to the liver during the course of the disease. The success of metastatic hepatic cancer treatment is strongly dependent on early diagnosis and understanding of the molecular mechanisms and biological behaviors of colorectal cancer, especially its infiltration and metastasis.By proteomics, we can develop new biomarkers for diagnosis and early detection of hepatic metastasis in CRC and accelerate drug exposure.展开更多
文摘Most colorectal cancer patients develop metastasis to the liver during the course of the disease. The success of metastatic hepatic cancer treatment is strongly dependent on early diagnosis and understanding of the molecular mechanisms and biological behaviors of colorectal cancer, especially its infiltration and metastasis.By proteomics, we can develop new biomarkers for diagnosis and early detection of hepatic metastasis in CRC and accelerate drug exposure.
